These immunotherapy technologies are very interesting. Initially, they will probably be used for people who are very ill, considering the potential side effects. I'm not sure how AE37 fits into this spectrum of treatments. However, the recent "Right to Try" legislation may be a boon to immunotherapy applications for cancer.